Skip to content

Freeline Therapeutics Holdings plc: filings

Every Freeline Therapeutics Holdings plc annual and quarterly report in the SEC record with the published financial measures it tagged, 3 filings, each linked to its SEC index.

Filing record ends 2023-04-04

The latest filing in this captured record is a 20-F filed 2023-04-04. No later filing is in the SEC companyfacts record captured on 2026-09-22. Freeline Therapeutics Holdings plc may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
20-F2023-04-04fiscal FY 2022471170000950170-23-011688
20-F2022-03-31fiscal FY 2021421070001564590-22-012988
20-F2021-03-31fiscal FY 2020401010001564590-21-017066

Inspect the source

Entity
Freeline Therapeutics Holdings plc / CIK 0001810031
Captured
SEC response SHA-256
b4d0f978f3f86c099115e0bc51f9867b8c5c732d772cf0adbe8cc0854b5526be

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001810031.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))